VulnerabilityAnalyzed
CVE-2025-52653
HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application.
MEDIUM 5.4EPSS 0.26%
Does this matter?
Lower severity and a low EPSS score (0.26%). Track it; it rarely justifies an emergency change on its own.
Description
HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.
- CVSS 3.1
- 5.4 MEDIUMCVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
- EPSS
- 0.26% probability · 18th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-79
- Affected
- hcltech/dryice myxalytics
- Source
- psirt@hcl.com
References
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.